Development and validation of a LC- MS/MS Method for simultaneous quantitation of telmisartan and pioglitazone in rat plasma
In majority of complex diseases like diabetes, multiple medications are essential to achieve the better therapeutic control, as several mediators are involved in their pathogenesis. Likewise, although the primary component of diabetes care is to control blood glucose level, management of cardiovascu...
Main Authors: | Das, Arindam, Sengupta, Pinaki, Ibrahim, Fuzianna, Chatterjee, Bappaditya, Mandal, Uttam Kumar |
---|---|
Format: | Conference or Workshop Item |
Language: | English |
Published: |
2016
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/52138/ http://irep.iium.edu.my/52138/7/52138.pdf |
Similar Items
-
Development and validation of a high throughput LC–MS/MS method for simultaneous quantitation of pioglitazone and telmisartan in rat plasma and its application to a pharmacokinetic study
by: Sengupta, Pinaki, et al.
Published: (2017) -
LC-MS-MS development and validation for simultaneous quantitation of metformin, glimepiride and pioglitazone in human plasma and its application to a bioequivalence study
by: Sengupta, Pinaki, et al.
Published: (2009) -
Beneficial alteration of blood biochemical parameters by Telmisartan-Pioglitazone combination in rat
by: Ibrahim, Fuzianna, et al.
Published: (2016) -
Safety profiling of pioglitazone and telmisartan combination by sub-chronic toxicity study in rat
by: Sengupta, Pinaki, et al.
Published: (2016) -
Assessment of preclinical pharmacokinetics and acute toxicity of pioglitazone and telmisartan combination
by: Sengupta, Pinaki Ranjan, et al.
Published: (2017)